We treated HCC cells with leupeptin and found that RP11-295G20.2-induced PTEN degradation in HCC cells was abrogated by the addition of leupeptin, a lysosomal cysteine protease inhibitor (Fig. 4b). Here, PTEN is linked to hepatocellular carcinoma.